An investigational drug did not significantly improve outcomes versus quetiapine extended release (Seroquel XR) as an adjunctive treatment in adults with major depressive disorder (MDD) and insomnia ...
Current Primary Outcome Measures •Percentage of Participants with Response (>=50 Percent improvement in MADRS total score from baseline) at Week 26 [ Time Frame: Week 26 ] -- Responders are defined as ...
The U.S Central Command continues to back the use of Seroquel, a powerful antipsychotic, to treat insomnia in troops deployed to combat zones despite an expert panel's recommendation six months ago to ...
May 24, 2007 (San Diego) — A recent study found that among patients in a psychiatric hospital, the atypical antipsychotic quetiapine (Seroquel, AstraZeneca), which is approved for schizophrenia and ...
The XR in SEROQUEL XR stands for extended release. This means that medication is released around the clock. SEROQUEL XR is taken once daily as prescribed by your health care professional. SEROQUEL XR ...
PHILADELPHIA — Pimavanserin (Nuplazid) is noninferior to quetiapine in patients with Parkinson's disease (PD) psychosis at 56 days, results from a phase 3 trial showed. In the first prospective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback